Table 2: Mean (±SD) values of fluorescence loss (∆F) and mineral loss (∆Z) in each experimental groups and percentage inhibition of demineralization (as measured by ∆F and ∆Z) by individual intervention formulations relative to the untreated control group.
Treatment Groups |
Mean ∆F ± SD |
% Inhibition of Fluorescence Loss Relative to Control |
Mean ∆Z ± SD |
% Inhibition of Mineral Loss Relative to Control |
Control (untreated) |
23.33±4.59 |
- |
933.2±183.6 |
- |
NaF |
19.69±2.82 |
15.6% |
771.85±110.54 |
17% |
0% S-PRG filler |
23.91±3.53b
|
-2.5% |
968.36±142.96b
|
-3.8% |
1% S-PRG filler |
12.00±2.47a,b,c
|
48.6% |
466.88±96.08a,b,c
|
50% |
5% S-PRG filler |
9.03±1.39a,b,c
|
61.3% |
360.79±55.53a,b,c
|
61.3% |
20% S-PRG filler |
7.60±1.09a,b,c,d
|
67.4% |
304.04±43.6a,b,c,d
|
67.4% |
30% S-PRG filler |
7.05±0.37a,b,c,d
|
69.8% |
274.95±14.43a,b,c,d
|
70.5% |
aSignificantly different from Control; bSignificantly different from NaF; cSignificantly different from 0% S-PRG filler; dSignificantly different from 1% S-PRG filler.